InvestorsHub Logo
Followers 32
Posts 7082
Boards Moderated 0
Alias Born 11/15/2010

Re: None

Wednesday, 06/05/2019 9:17:10 AM

Wednesday, June 05, 2019 9:17:10 AM

Post# of 21536
Couple of thoughts from a quasi-moron: (me). Could not believe how few people were at Dr. Alkon's talk at Penn, day before yesterday. They say University City. Don't know what that's all about. It was Penn and his alma mater (and mine)

If he'd given it at the Harrison Lab lecture hall on 34th street, where he spent five years--at least--it would have been packed. Well, maybe not now, since the school year is over. But, certainly, during it.

And does anyone look at this as a potential, major, growth company? Just like AXSM and ARWR, improving the life of neurons will be huge, and, oonceivably, for problems no one has even thought of. Reminds me of Amgen and erythropoietin. Only time will tell, but the odds are, distinctly, in Neurotrope's favor.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News